Medizone/OTC: MZEI (AIDS and Hepatitis B Treatment) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medizone/OTC: MZEI (AIDS and Hepatitis B Treatment)

MZEI 0.00500

-18.0%

Oct 4 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: gtoland who wrote (768)	5/31/2000 7:03:00 PM
From: gtoland	Read Replies (1) of 783

The scientific stuff will have to be told by others at the meeting. they have a total of 4 patients owned or filed for. They are going to be filing for a 5th on soon. 1. Ozone decontamination of blood & blood products, this expires in 2003 and they will extend it beyond. 2. Apparatus for the controlled generation & administration of ozone, received in 1995 till ?. 3. External application of ozone/oxygen for pathogenic conditions, received in 1999 till ?. 4. Filed for this year, Methods & apparatus for ozone decontamination of biological liquid. 5. Anticipated filing this year, Ozone/blood, serum cartridge. They did not talk much about this product as they have not filed for the patient as of this meeting. more later. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next